Commentary on: Treatment of HCV infection in chronic kidney disease
Read
6528
Timeswas read the article
2117
Total PDF
4411
Total HTML
Share statistics
array:21 [ "pii" => "X2013251411052471" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Jun.10983" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:607" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3388 "formatos" => array:3 [ "EPUB" => 288 "HTML" => 2583 "PDF" => 517 ] ] "Traduccion" => array:1 [ "en" => array:17 [ "pii" => "X0211699511052474" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2011.Jun.10983" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2011;31:607" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3354 "formatos" => array:3 [ "EPUB" => 298 "HTML" => 2595 "PDF" => 461 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Commentary on: Treatment of HCV infection in chronic kidney disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "607" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Commentary on: Treatment of HCV infection in chronic kidney disease" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S.M. Alavian" "autores" => array:1 [ 0 => array:2 [ "Iniciales" => "S.M." "apellidos" => "Alavian" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251411052471" "doi" => "10.3265/Nefrologia.pre2011.Jun.10983" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052471?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511052474?idApp=UINPBA000064" "url" => "/02116995/0000003100000005/v0_201502091408/X0211699511052474/v0_201502091409/en/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251411052463" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Aug.11119" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:607-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3535 "formatos" => array:3 [ "EPUB" => 287 "HTML" => 2783 "PDF" => 465 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Response to the comment made on Treatment of HCV infection in chronic kidney disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "607" "paginaFinal" => "608" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta al comentario sobre el Manejo de la infección por el virus de la hepatitis C en la enfermedad renal crónica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rebeca García Agudo, R. García Agudo, Sami Aoufi Rabih, S. Aoufi Rabih" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Rebeca" "apellidos" => "García Agudo" ] 1 => array:2 [ "Iniciales" => "R." "apellidos" => "García Agudo" ] 2 => array:2 [ "nombre" => "Sami" "apellidos" => "Aoufi Rabih" ] 3 => array:2 [ "Iniciales" => "S." "apellidos" => "Aoufi Rabih" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699511052466" "doi" => "10.3265/Nefrologia.pre2011.Aug.11119" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511052466?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052463?idApp=UINPBA000064" "url" => "/20132514/0000003100000005/v0_201502091634/X2013251411052463/v0_201502091634/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X201325141105248X" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.May.10869" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:602-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5625 "formatos" => array:3 [ "EPUB" => 278 "HTML" => 4640 "PDF" => 707 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Regression of vascular calcification in a patient treated with cinacalcet: A case report" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "602" "paginaFinal" => "606" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Regresión de la calcificación vascular en un paciente tratado con cinacalcet: informe de un caso" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10869_108_21698_en_f1_a_y_b_10869.jpg" "Alto" => 243 "Ancho" => 600 "Tamanyo" => 108899 ] ] "descripcion" => array:1 [ "en" => "(A) Anteroposterior X-ray of left hand in 2006. (B) Anteroposterior X-ray of left hand in 2007" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Salgueira, A.I. Martínez, J.A. Milán" "autores" => array:3 [ 0 => array:2 [ "Iniciales" => "M." "apellidos" => "Salgueira" ] 1 => array:2 [ "Iniciales" => "A.I." "apellidos" => "Martínez" ] 2 => array:2 [ "Iniciales" => "J.A." "apellidos" => "Milán" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699511052482" "doi" => "10.3265/Nefrologia.pre2011.May.10869" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511052482?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325141105248X?idApp=UINPBA000064" "url" => "/20132514/0000003100000005/v0_201502091634/X201325141105248X/v0_201502091634/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Commentary on: Treatment of HCV infection in chronic kidney disease" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "607" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "S.M. Alavian" "autores" => array:1 [ 0 => array:4 [ "Iniciales" => "S.M." "apellidos" => "Alavian" "email" => array:1 [ 0 => "alavian@thc.ir" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => " Director of Baqiyatallah Research Center for Gastroenterology and Liver Disease, Tehran, Iran, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Dear Editor:</span></p><p class="elsevierStylePara">I read with interest the published article by Aoufi Rabih<span class="elsevierStyleSup">1</span> in your journal recently. The prevalence of Hepatitis C virus (HCV) infection in hemodialysis (HD) patients varies markedly from country to country<span class="elsevierStyleSup">2</span>. The main risk factors for HCV infection in this special group are blood transfusions, length of dialysis time and nosocomial routes of transmission including the use of contaminated equipment and patient-to-patient exposure<span class="elsevierStyleSup">3-6</span>. Control of HCV infection in hemodialysis setting is possible<span class="elsevierStyleSup">7,8</span>. Integration of surveillance system for early detection, treating all of treatable patients with alpha interferon, putting HCV-infected patients on the top list for renal transplantation, training the staffs in hemodialysis patients and using more the erythropoietin instead blood transfusion. The prevalence of HCV infection may be underestimated according to an antibody assay alone<span class="elsevierStyleSup">9</span>. First of all, I would like to present a dilemma regarding liver biopsy in hemodialysis patients with HCV infection. Liver biopsy in hemodialysis patients is with higher risk of bleeding and other complication and it should do by Trans-jugular or in very specialized center. In treatment of HCV infection in hemodialysis patients, we are not sure regarding superiority of pegylated interferon (IFN) on conventional IFN<span class="elsevierStyleSup">10,11</span> and in a meta-analysis The pooled sustained virologic response (SVR) for standard and pegylated IFN monotherapy in random effects model was 39.1% (95% confidence interval [CI], 32.1 to 46.1) and 39.3% (95% CI, 26.5 to 52.1), respectively<span class="elsevierStyleSup">10</span>. The difference was not significant, but it is important to treat the patients before 40 years old and as soon as possible<span class="elsevierStyleSup">10,12</span>. Individuals on dialysis with chronic hepatitis C who were treated with interferon or pegylated interferon plus ribavirin can have higher SVR rate than dialysis patients treated with interferon or pegylated interferon alone. Administration of ribavirin with close monitoring of CBC and serum ribavirin concentration can be safe<span class="elsevierStyleSup">13</span>.</p>" "pdfFichero" => "P1-E524-S3360-A10983-EN.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:13 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "1.\u{A0}Aoufi Rabih S, García Agudo R. Treatment of HCV infection in chronic kidney disease. Nefrologia 2011;31(3):260-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21407274" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "2.\u{A0}Alavian SM, Tabatabaei SH, Mahboobi N. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature. J Public Health (Oxf) 2011;19:191-203." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "3.\u{A0}Alavian SM. A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol 2009;15(6):641-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19222088" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "4.\u{A0}Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: A systematic review. Hemodial Int 2010;14(3):253-62. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20491973" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "5.\u{A0}Mansour-Ghanaei F, Sadeghi A, Mashhour MY, Joukar F, Besharati S, Roshan ZA, et al. Prevalence of hepatitis B and C infection in hemodialysis patients of Rasht (Center of Guilan Province, Northern Part of Iran). Hepat Mon 2009;9(1):45-9." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "6.\u{A0}Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton) 2003;8(5):256-60." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "7.\u{A0}Alavian SM. Hepatitis C, chronic renal failure, control is possible! Hepat Mon 2006;6(2):51-2." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "8.\u{A0}Nemati E, Taheri S, Einollahi B. Hepatitis C among hemodialysis patients: impact of strict adherence to universal precautions. Hepat Mon 2007;7(4):245-6." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "9.\u{A0}Einollahi B, Alavian SM. Hepatitis C virus infection and kidney transplantation: a review for clinicians. Iran J Kidney Dis 2010;4(1):1-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20081297" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "10.\u{A0}Alavian SM, Tabatabaei SV. Meta-analysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection. Iran J Kidney Dis 2010;4(3):181-94. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20622305" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "11.\u{A0}Hosseini Moghaddam SM, Alavian SM, Rahnavardi M. Therapeutic aspects of hepatitis C in hemodialysis patients. Am J Nephrol 2009;29(2):123-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18719345" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "12.\u{A0}Alavian SM, Hosseini-Moghaddam SM, Rahnavardi M. Hepatitis C among hemodialysis patients: a review on epidemiologic, diagnostic, and therapeutic features. Hepat Mon 2007;7(3):153-62." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "13.\u{A0}Alavian SM, Tabatabaee V, Lankarani KB. Ribavirin combination therapy of chronic hepatitis C patients with end stage renal disease: review of evidences on efficacy and safety. Int J Nephrol Urol 2011;3(1):1-7." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:1 [ "itemHostRev" => array:3 [ "pii" => "S073510970903006X" "estado" => "S300" "issn" => "07351097" ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003100000005/v0_201502091634/X2013251411052471/v0_201502091634/en/main.assets" "Apartado" => array:4 [ "identificador" => "35439" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor - Comments on published articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003100000005/v0_201502091634/X2013251411052471/v0_201502091634/en/P1-E524-S3360-A10983-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052471?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 6 | 11 |
| 2024 October | 36 | 29 | 65 |
| 2024 September | 44 | 22 | 66 |
| 2024 August | 53 | 57 | 110 |
| 2024 July | 32 | 29 | 61 |
| 2024 June | 40 | 30 | 70 |
| 2024 May | 48 | 27 | 75 |
| 2024 April | 37 | 37 | 74 |
| 2024 March | 32 | 18 | 50 |
| 2024 February | 33 | 38 | 71 |
| 2024 January | 30 | 30 | 60 |
| 2023 December | 25 | 23 | 48 |
| 2023 November | 52 | 24 | 76 |
| 2023 October | 45 | 27 | 72 |
| 2023 September | 60 | 31 | 91 |
| 2023 August | 36 | 19 | 55 |
| 2023 July | 35 | 22 | 57 |
| 2023 June | 33 | 20 | 53 |
| 2023 May | 31 | 29 | 60 |
| 2023 April | 33 | 13 | 46 |
| 2023 March | 64 | 18 | 82 |
| 2023 February | 51 | 23 | 74 |
| 2023 January | 25 | 25 | 50 |
| 2022 December | 34 | 37 | 71 |
| 2022 November | 34 | 32 | 66 |
| 2022 October | 30 | 41 | 71 |
| 2022 September | 37 | 27 | 64 |
| 2022 August | 44 | 53 | 97 |
| 2022 July | 20 | 43 | 63 |
| 2022 June | 33 | 35 | 68 |
| 2022 May | 28 | 32 | 60 |
| 2022 April | 28 | 41 | 69 |
| 2022 March | 40 | 51 | 91 |
| 2022 February | 35 | 39 | 74 |
| 2022 January | 26 | 24 | 50 |
| 2021 December | 33 | 40 | 73 |
| 2021 November | 23 | 34 | 57 |
| 2021 October | 37 | 42 | 79 |
| 2021 September | 22 | 43 | 65 |
| 2021 August | 28 | 40 | 68 |
| 2021 July | 33 | 36 | 69 |
| 2021 June | 22 | 20 | 42 |
| 2021 May | 20 | 39 | 59 |
| 2021 April | 45 | 49 | 94 |
| 2021 March | 30 | 36 | 66 |
| 2021 February | 15 | 18 | 33 |
| 2021 January | 32 | 25 | 57 |
| 2020 December | 13 | 15 | 28 |
| 2020 November | 24 | 13 | 37 |
| 2020 October | 13 | 15 | 28 |
| 2020 September | 12 | 6 | 18 |
| 2020 August | 30 | 14 | 44 |
| 2020 July | 25 | 10 | 35 |
| 2020 June | 16 | 7 | 23 |
| 2020 May | 24 | 10 | 34 |
| 2020 April | 24 | 18 | 42 |
| 2020 March | 19 | 10 | 29 |
| 2020 February | 30 | 19 | 49 |
| 2020 January | 35 | 17 | 52 |
| 2019 December | 30 | 20 | 50 |
| 2019 November | 27 | 22 | 49 |
| 2019 October | 7 | 7 | 14 |
| 2019 September | 28 | 20 | 48 |
| 2019 August | 20 | 5 | 25 |
| 2019 July | 25 | 23 | 48 |
| 2019 June | 13 | 9 | 22 |
| 2019 May | 14 | 11 | 25 |
| 2019 April | 29 | 32 | 61 |
| 2019 March | 15 | 25 | 40 |
| 2019 February | 13 | 16 | 29 |
| 2019 January | 27 | 13 | 40 |
| 2018 December | 59 | 32 | 91 |
| 2018 November | 70 | 15 | 85 |
| 2018 October | 57 | 15 | 72 |
| 2018 September | 49 | 13 | 62 |
| 2018 August | 75 | 20 | 95 |
| 2018 July | 49 | 13 | 62 |
| 2018 June | 42 | 14 | 56 |
| 2018 May | 54 | 18 | 72 |
| 2018 April | 42 | 7 | 49 |
| 2018 March | 44 | 6 | 50 |
| 2018 February | 45 | 5 | 50 |
| 2018 January | 31 | 11 | 42 |
| 2017 December | 38 | 7 | 45 |
| 2017 November | 24 | 2 | 26 |
| 2017 October | 28 | 6 | 34 |
| 2017 September | 35 | 9 | 44 |
| 2017 August | 29 | 4 | 33 |
| 2017 July | 28 | 15 | 43 |
| 2017 June | 45 | 9 | 54 |
| 2017 May | 46 | 8 | 54 |
| 2017 April | 37 | 5 | 42 |
| 2017 March | 15 | 15 | 30 |
| 2017 February | 19 | 10 | 29 |
| 2017 January | 19 | 6 | 25 |
| 2016 December | 32 | 3 | 35 |
| 2016 November | 41 | 8 | 49 |
| 2016 October | 60 | 4 | 64 |
| 2016 September | 62 | 1 | 63 |
| 2016 August | 101 | 4 | 105 |
| 2016 July | 87 | 1 | 88 |
| 2016 June | 86 | 0 | 86 |
| 2016 May | 101 | 0 | 101 |
| 2016 April | 50 | 0 | 50 |
| 2016 March | 47 | 0 | 47 |
| 2016 February | 85 | 0 | 85 |
| 2016 January | 91 | 0 | 91 |
| 2015 December | 103 | 0 | 103 |
| 2015 November | 69 | 0 | 69 |
| 2015 October | 56 | 0 | 56 |
| 2015 September | 50 | 0 | 50 |
| 2015 August | 54 | 0 | 54 |
| 2015 July | 56 | 0 | 56 |
| 2015 June | 30 | 0 | 30 |
| 2015 May | 42 | 0 | 42 |
| 2015 April | 6 | 0 | 6 |
Show all
